Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2905 studies found for:    "Carcinoma, Non-Small-Cell Lung"
Show Display Options
Download search resultsDownload the search results for:
"Carcinoma, Non-Small-Cell Lung" (2905 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer
Conditions: Non-Small-Cell Lung Cancer Stage IIIB;   Non-Small-Cell Lung Cancer Stage IV;   Non-Small-Cell Lung Cancer Metastatic;   Carcinoma, Non-Small-Cell Lung;   Non-Small Cell Lung Cancer;   Non-Small-Cell Lung Carcinoma;   Nonsmall Cell Lung Cancer
Interventions: Biological: bavituximab;   Drug: Docetaxel;   Other: Placebo (for bavituximab)
2 Completed Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma;   Carcinoma, Non-Small Cell Lung;   Lung Neoplasms
Intervention: Drug: EKB-569
3 Recruiting Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung;   Non-Small Cell Lung Cancer
Interventions: Drug: CC-223, erlotinib;   Drug: CC-223, oral azacitidine
4 Completed Pharmacogenomic Study Realized on "Non-small Cell Lung Carcinoma"
Condition: Carcinoma, Non-Small-Cell Lung
Intervention:
5 Completed Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: SGN-15;   Drug: Docetaxel
6 Terminated Sorafenib in Resected Non-small Cell Lung Carcinoma
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Sorafenib
7 Completed Study of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma
Condition: Non-Small-Cell Lung Carcinoma
Intervention: Drug: ILX651
8 Completed An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma
Conditions: Carcinoma, Non-Small-Cell Lung;   Neoplasm Metastasis
Intervention: Drug: Cetuximab
9 Completed FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma
Condition: Non-Small Cell Lung Carcinoma
Intervention: Drug: SGN-15, Docetaxel
10 Recruiting Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study.
Condition: Non Small Cell Lung Carcinoma
Intervention:
11 Completed FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer
Intervention: Drug: FR901228
12 Not yet recruiting Pazopanib in Molecularly Selected Patients With Advanced NSCLC
Conditions: Carcinoma, Non-Small Cell Lung;   Non-Small Cell Lung Cancer;   Nonsmall Cell Lung Cancer
Intervention: Drug: Pazopanib
13 Unknown  Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer;   Lung Cancer;   Stage IIIA Non Small Cell Lung Cancer;   Stage IIIB Non Small Cell Lung Cancer
Intervention: Drug: S-3304
14 Terminated Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy
Conditions: Carcinoma, Non-small Cell Lung;   Lung Cancer
Intervention: Drug: Satraplatin
15 Recruiting Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II
Conditions: Non-small Cell Lung Cancer;   Advanced Non-small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Hydroxychloroquine;   Drug: Bevacizumab
16 Withdrawn Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell-Lung
Intervention: Drug: Temoporfin
17 Recruiting Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation
Conditions: Cachexia;   Fatigue;   Pulmonary Complications;   Radiation Toxicity;   Recurrent Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Behavioral: exercise intervention;   Procedure: pulmonary complications management/prevention;   Procedure: quality-of-life assessment;   Other: questionnaire administration
18 Active, not recruiting A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small Cell-Lung;   Lung Neoplasms;   Lung Cancer;   Respiratory Tract Neoplasms
Interventions: Biological: AV-299 + gefitinib;   Drug: Gefitinib
19 Recruiting Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Lenalidomide
20 Active, not recruiting Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non Small Cell Lung
Interventions: Drug: Docetaxel;   Drug: Suramin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years